Skip to main content
OpenTrials
Completed

NCT Number: NCT06099002

Balance, Walking Speed, Quadriceps Femoris Muscle Strength and Quality of Life in Falling and Non-falling Individuals With COPD

A descriptive study evaluating balance, gait speed, Quadriceps Femoris muscle strength and quality of life in individuals with Chronic obstructive pulmonary disease (COPD) who fell and did not fall.

Completed

Looking for future studies?

Notify Me

Key information

Age range

65 year–84 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Kirikkale High Specialization Hospital

Kirikkale, Merkez, 71100, Turkey (Türkiye)

About this study

Falls in the elderly can have devastating consequences. The ability to maintain stability and balance is critical for functional independence, mobility, and avoidance of falls in activities of daily living. An impaired balance is associated with an increased risk of falls and causes a higher mortality rate among older adults. Balance impairment is independently associated with falls in patients with Chronic obstructive pulmonary disease. Well-known risk factors for falls in individuals with Chronic obstructive pulmonary disease include advanced age, increased comorbidities, dyspnea, physical inactivity, muscle weakness, fear and decreased balance confidence, as well as lower extremity muscle weakness. It has been reported that there are functional deficiencies, lack of performance and postural control. According to the results of a recent study, it was found that Chronic obstructive pulmonary disease is in the second place after osteoarthritis in chronic conditions where the prevalence of falls is highest. The prevalence of falls in individuals with Chronic obstructive pulmonary disease is estimated to range from 25% to 46%.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Being diagnosed with COPD according to criteria
  • Not having had an attack in the last 2 months
  • Volunteering to participate in the study
  • Being 65 years or older
  • Not having any mental or communication problems that prevent filling out the surveys to be used in the research.

Exclusion criteria

  • Having unstable COPD
  • Unstable angina, previous Myocardial Infarction, uncontrolled hypertension, cancer, neurological or musculoskeletal diseases with functional limitations
  • Being currently addicted to alcohol or drugs
  • Being in the process of COPD exacerbation
  • Having severe vision and hearing problems
  • Having severe cognitive impairment
  • Having had major surgery in the last few months

Treatment and study plan

Changed Medical research Council,Mini Mental Test, Quadriceps Femoris muscle strength measurement,2 min walking test, fall effectiveness scale,Fall risk self-assessment scale

Other

All individuals were given a respiratory function test to evaluate respiratory functions before and after training Modified Medical research Council to evaluate dyspnea, Mini Mental Test to evaluate cognitive status

, Berg Balance Test to evaluate balance, 2-minute walk test to evaluate walking speed. A hand dynamometer will be used to measure QuadricepsFemoris muscle strength, Fall efficiency scale Fall risk self-assessment scale will be used to evaluate falls.

Primary outcomes

  1. Fall Effectiveness Scale

    Time frame: 15.04.2023-30.09.2024

    It contains 10 questions. Each question is given a score between 1-10. 1 point means very confident, 10 points means not at all confident. A patient with a score above 70 is said to have a fear of falling.

Secondary outcomes

  1. To measure balance Berg Balance Scala

    Time frame: 15.04.2023-30.09.2024

    To assess balance. The highest score is 56, scores between 0-20 indicate that the balance is disrupted, 21-41 indicates that the balance is acceptable, and 41-56 indicates that the balance is good.

  2. Quadriceps Femoris muscle strength falling and non-falling individuals with COPD

    Time frame: 15.04.2023-30.09.2024

    We measure the strength of the muscle by applying pressure from the knee with the help of a hand dynamometer.

  3. Two Minute Walk Test

    Time frame: 15.04.2023-30.09.2024

    The patient walks the longest distance he can in 2 minutes and the value is recorded in meters. The aim is to measure the patient's functional capacity.

Sponsors and collaborators

Lead sponsor

Kırıkkale University

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Oct 25, 2023
Registry last updated
Oct 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.